Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Abiomed, Inc. (NasdaqNM:ABMD)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Location
22 Cherry Hill Drive
Danvers, MA 01923
Phone: (978) 777-5410
Fax: (978) 777-1561
Email: ir@abiomed.com
Employees (last reported count): 264
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 40%
·Institutional: 24% (41% of float)
(88 institutions)
·Net Inst. Buying: 146.0K shares (+2.78%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Abiomed, Inc. is a developer, manufacturer, and marketer of medical products designed to safely and effectively assist or replace the pumping function of the failing heart. The Company's current commercial products and primary products under development are the BVS product line and the AbioCor system, respectively. Both of these products are systems, or product lines, that consist of various component products. In addition, the Company is in the early stages of research and development of other potential products for heart failure patients.
More from Market Guide: Expanded Business Description

Financial Summary
Abiomed Inc. is engaged in the research, development and sale of medical devices with a primary focus on cardiac assist and heart replacement systems. For the three months ended 6/30/01, revenues rose 2% to $6 million. Net loss totaled $6.3 million, up from $2 million. Revenues reflect increased international sales of BVS(R) blood pumps. Higher loss reflects higher research and development costs for the AbioCor and Penn State Heart implantable replacement hearts.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

David Lederman, Ph.D., 55
Chairman, Pres, CEO
$516K
John Thero, 39
Sr. VP-Fin., Treasurer, CFO
259K
James Koert
Sr. VP, Market Devel.
--  
Robert T. Kung, Ph.D., 56
Sr. VP and CSO
266K
Eugene Rabe, 44
Sr. VP- Global Sales and Services
249K
Dollar amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:ABMDAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Apr-2001
$10.50 
Recent Price$18.75 
52-Week High
on 10-Oct-2000
$37.75 
Beta0.58 
Daily Volume (3-month avg)158.6K
Daily Volume (10-day avg)120.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-40.1%
52-Week Change
relative to S&P500
-19.7%
Share-Related Items
Market Capitalization$390.5M
Shares Outstanding20.8M
Float12.5M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 2-Oct-2000
Per-Share Data
Book Value (mrq)$4.93 
Earnings (ttm)-$0.76 
Earnings (mrq)-$0.30 
Sales (ttm)$1.21 
Cash (mrq)$4.23 
Valuation Ratios
Price/Book (mrq)3.80 
Price/EarningsN/A 
Price/Sales (ttm)15.48 
Income Statements
Sales (ttm)$25.0M
EBITDA (ttm)-$17.8M
Income available to common (ttm)-$15.7M
Profitability
Profit Margin (ttm)-62.8%
Operating Margin (ttm)-85.1%
Fiscal Year
Fiscal Year EndsMar 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-13.26%
Return on Equity (ttm)-14.27%
Financial Strength
Current Ratio (mrq)11.39 
Debt/Equity (mrq)0.00 
Total Cash (mrq)$88.1M
Short Interest
As of 8-Aug-2001
Shares Short3.92M
Percent of Float31.3%
Shares Short
(Prior Month)
3.95M
Short Ratio36.25 
Daily Volume108.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.